We are home to a collaboration of interlinked neurological research areas focused on advancing scientific knowledge to further patient recovery and management.
Our mission is to transform the lives of people living with epilepsy for the better by identifying, understanding and preventing the underlying mechanisms.
We are a world-leading group that brings together expertise across the clinical and basic science spectrum of the physiology of human movement and movement disorders.
We include staff located in the Leopold Muller Functional imaging laboratory (FIL) and the Max Planck UCL Centre for Computational Psychiatry and Ageing Research.
We have strong focus on mechanistic dissection of genetic, molecular cellular and neuropathological processes which underlie neurodegeneration in particular diseases.
The main focus of the department is research into multiple sclerosis and we employ a broad range of basic and clinical methods, including clinical therapeutic trials.
We are a hub for clinical and research excellence across the spectrum of spinal cord and neuromuscular diseases, focused on developing novel therapeutic solutions.
UCL was selected as the hub of the UK Dementia Research Institute to advance understanding of neurodegeneration and therapeutic approaches for dementia.